Pharmaceutical composition for treating wind-phlegm collateral obstruction type ischemic stroke

The invention discloses a pharmaceutical composition for treating a wind-phlegm collateral obstruction type ischemic stroke. The pharmaceutical composition is prepared from, by weight, 10-14 parts of rhizoma atractylodis, 10-14 parts of poria cocos, 10-14 parts of coix seeds, 8-10 parts of dried tan...

Full description

Saved in:
Bibliographic Details
Main Authors ZHANG GUANGSHENG, DENG JIANFEI
Format Patent
LanguageChinese
English
Published 21.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses a pharmaceutical composition for treating a wind-phlegm collateral obstruction type ischemic stroke. The pharmaceutical composition is prepared from, by weight, 10-14 parts of rhizoma atractylodis, 10-14 parts of poria cocos, 10-14 parts of coix seeds, 8-10 parts of dried tangerine or orange peel, 5-7 parts of fructus amomi, 8-10 parts of rhizoma alismatis, 13-17 parts of milkvetch roots, 10-14 parts of the root of red-rooted salvia, 10-14 parts of hawthorn fruits, 5-7 parts of earthworms, 2-4 parts of whole scorpions, 2-4 parts of centipedes and 8-10 parts of zaocys dhumnade. The defects of existing medicine for treating the wind-phlegm collateral obstruction type ischemic stroke are overcome, and the pharmaceutical composition is good in wind-phlegm collateral obstruction type ischemic stroke treatment effect. 本发明公开了种治疗风痰阻络型缺血性中风的药物组合物,由以下述重量份的原料药制成:苍术10-14份、茯苓10-14份、薏苡仁10-14份、陈皮8-10份、砂仁5-7份、泽泻8-10份、黄芪13-17份、丹参10-14份、山楂10-14份、地龙5-7份、全蝎2-4份、蜈蚣2-4份、乌梢蛇8-10份,克服现有治疗风痰阻络型缺血性中风药物的不足,提供种治疗风
Bibliography:Application Number: CN20161420247